Amicus Therapeutics, Inc. (FOLD) Social Stream
AMICUS THERAPEUTICS INC (FOLD) Price Targets From Analysts
Use the tables below to see what analysts covering AMICUS THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 11 | $29 | $12 | $18.333 | $11.49 | 59.56% |
| 2021-11-15 | 10 | $29 | $12 | $18.444 | $11.49 | 60.52% |
| 2021-11-23 | 9 | $29 | $12 | $17.5 | $11.49 | 52.31% |
| 2022-01-13 | 9 | $29 | $12 | $17.375 | $11.49 | 51.22% |
| 2022-01-17 | 9 | $29 | $15 | $17.875 | $11.49 | 55.57% |
| 2022-01-26 | 9 | $29 | $15 | $17.5 | $11.49 | 52.31% |
| 2022-02-25 | 9 | $29 | $14 | $17 | $11.49 | 47.95% |
| 2022-04-20 | 9 | $20 | $14 | $15.5 | $11.49 | 34.9% |
| 2022-05-10 | 10 | $20 | $11 | $15 | $11.49 | 30.55% |
| 2022-05-12 | 8 | $20 | $11 | $15.125 | $11.49 | 31.64% |
| 2022-08-05 | 7 | $20 | $11 | $15 | $11.49 | 30.55% |
| 2022-08-13 | 7 | $20 | $11 | $15.142 | $11.49 | 31.78% |
| 2022-10-19 | 8 | $20 | $11 | $15 | $11.49 | 30.55% |
| 2022-11-07 | 8 | $20 | $11 | $15.125 | $11.49 | 31.64% |
| 2022-11-15 | 8 | $20 | $11 | $15.375 | $11.49 | 33.81% |
The Trend in the Analyst Price Target
FOLD's average price target has moved down $1 over the prior 16 months.
FOLD reports an average of 66.6% for its upside potential over the past 44 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-08-05 | 7 | 20 | 11 | 15.285 | 12.18 | 25.49% |
| 2022-08-12 | 7 | 20 | 11 | 15.142 | 12.32 | 22.91% |
| 2022-09-17 | 8 | 20 | 11 | 15.000 | 10.62 | 41.24% |
| 2022-10-03 | 8 | 20 | 11 | 15.000 | 10.70 | 40.19% |
| 2022-10-06 | 8 | 20 | 11 | 15.000 | 10.87 | 37.99% |
FOLD Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 6 | 0 | 2 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
FOLD's average broker recommendation rating worsened by 0.21 over the prior 92 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how AMICUS THERAPEUTICS INC fares relative to all US stocks, note that its average analyst price target is greater than 402.91% of that group.
- AMICUS THERAPEUTICS INC's variance in analysts' estimates is lower than -1404.97% of all US stocks.
- In the context of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 449.92% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMICUS THERAPEUTICS INC's number of analysts covering the stock is greater than 1436.16% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMICUS THERAPEUTICS INC are CORT, INVA, and ACAD.
View All Top Stocks by Price Target
Is FOLD a Buy, Hold or Sell? See the POWR Ratings now!